Doctor profile · Federal record
Dr. Sirimon Reutrakul, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Chicago, IL
- NPI 1457448334
- Accepts Medicare
- MIPS 77.1 / 100 · 2023
- 34 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1725 W Harrison St, Ste 250
Chicago, IL 606123841
(312) 942-6163
fax (312) 563-2096
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 21, 2009
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Illinois #036092151
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457448334. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
123
Distinct HCPCS
3
Medicare allowed
$10,039
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 81 | 53 | $101 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 31 | 18 | $35 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 11 | 11 | $70 |
In context: peer comparison
Among 41 peers in Chicago Endocrinology, Diabetes & Metabolism Physician, average services per provider: 186. This provider delivers 0.7× the peer median.Open Payments
Industry payments received
All-time total
$26
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 1 | $26.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
698
Patients
90
Total drug cost
$371,678
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 112 | 26 | $2,263 |
| Ozempic (Semaglutide) | Brand | 92 | 14 | $107,727 |
| Trulicity (Dulaglutide) | Brand | 83 | 20 | $99,858 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 62 | 17 | $24,295 |
| Jardiance (Empagliflozin) | Brand | 43 | 0 | $28,756 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 41 | 13 | $4,146 |
| Praluent Pen (Alirocumab) | Brand | 35 | 0 | $16,968 |
| Ultra-Fine Nano Pen Needle (Pen Needle, Diabetic) | Brand | 34 | 0 | $2,200 |
| Novolog Flexpen (Insulin Aspart) | Brand | 31 | 0 | $23,010 |
| Trueplus Pen Needle (Pen Needle, Diabetic) | Brand | 31 | 0 | $507 |
Frequently asked questions
What is Dr. Sirimon Reutrakul's medical specialty?
Dr. Sirimon Reutrakul practices Endocrinology, Diabetes & Metabolism Physician in Chicago, IL.
Where does Dr. Sirimon Reutrakul practice?
Dr. Sirimon Reutrakul practices at 1725 W Harrison St, Chicago, IL 606123841. Office phone: 3129426163.
What is Dr. Sirimon Reutrakul's NPI?
Dr. Sirimon Reutrakul's National Provider Identifier (NPI) is 1457448334, issued by NPPES.
Does Dr. Sirimon Reutrakul accept Medicare assignment?
Yes. Dr. Sirimon Reutrakul accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sirimon Reutrakul commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.